SFRP4 may therefore potentially be useful in the selection of candidates for active surveillance as well as for patients in need of adjuvant or more aggressive treatment, and SFRP4 deserves further attention in prostate cancer studies. This evidence concerns the gene SFRP4 and Familial prostate cancer.